Venture capital funds, in which Russian Venture Company (RVC) has major stakes, have invested about $83m in biotech and medical equipment projects so far, reports, citing RVC CEO Igor Agamirzyan.
According to Mr. Agamirzyan, biomed is a priority for all RVC-spawned VC funds.
The funds have invested a total of $280+m in all technology projects, he added.
Russian Venture Company is a government-owned ‘fund of funds’, one of the Russian government’s key instruments in creating a new innovation economy.